NeutralLOW severityEarnings28m ago

MannKind anticipates $1B in revenue from United Therapeutics deal from 2027-2030 as it targets Q4 profitability

MannKind anticipates $1B in revenue from United Therapeutics deal from 2027-2030 as it targets Q4 profitability — $MNKD one-month chart
$MNKD daily closes over the past month · Wook of Wall Street artwork from market data
WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Ask about MNKD. Get explanations, comparisons and calculations with the source lookups shown.

Wook analysis

What it means

Key points
  • What to watch: The earnings call often says more than the earnings — tone on demand, costs and the next quarter is the thing to hear.
  • How the stocks are trading: $MNKD -4.33%, $UTHR -7.03% in the latest session.
  • Timing: It came out pre-market, so the next session was the first that could react.
Amount$1 billion

Where the stock stands

$MNKD last changed hands at $3.76, -4.33% on the session, 42% below its 52-week high of $6.51 and 69% above its low of $2.23 — a little below the middle of the range. Over the year it has ranged 192% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. $UTHR last traded at $565.72, -7.03% on the session. That puts it 7.9% shy of its 52-week high of $614.23 and 27% clear of its low of $444.04 — in the upper part of the range. Over the year it has ranged 38% from low to high: a moderate band — lively, not wild. These are latest-session quotes, not live prices.

How much coverage it is getting

Wook has logged 8 stories on these names in the last 30 days, 3 of them this week. At its 30-day pace you would expect about 2 a week, so this week is running well ahead of normal; the press has found a reason to keep writing. Across those stories 0 read bullish, 8 neutral and 0 bearish. This one reads neutral, so it sits in step with most of the run. 2 came from Seeking Alpha and the rest from other outlets — broad coverage, not one desk talking to itself. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.

The bigger picture

With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. On Wook's supply-chain scanner, Health Care reads watch today — early signs of strain worth keeping an eye on.

What to watch next

For the receipts, the $MNKD page has the full chart, the filings and the valuation model these figures come from. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. And Wook AI, up top, will happily do the math — how far $MNKD sits from its high, or how this week's coverage stacks up.

How this analysis was made

Seeking Alpha published it, and Wook filed it under Earnings. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $MNKD and $UTHR; a company mentioned in passing is tagged the same as the subject, so check which one the story is really about. It carried $1 billion, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.

The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.

Discussion

No one has weighed in yet. Start the discussion on this story.

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.

Choose what this browser shares. Essential sign-in and security cookies stay on.

Read the privacy policy